Stem cell transplant

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

Immune Ablation and Stem Cell Support for Crohn's Disease

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Autologous Transplant for Multiple Myeloma

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation

Combined Haploidentical-Cord Blood Transplantation for Adults and Children

Stem Cell Transplant for Hematological Malignancy

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies